BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 18363539)

  • 1. Gynecomastia possibly induced by rosuvastatin.
    Oteri A; Catania MA; Travaglini R; Russo A; Giustini SE; Caputi AP; Polimeni G
    Pharmacotherapy; 2008 Apr; 28(4):549-51. PubMed ID: 18363539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent acute pancreatitis possibly induced by atorvastatin and rosuvastatin. Is statin induced pancreatitis a class effect?
    Singh S; Nautiyal A; Dolan JG
    JOP; 2004 Nov; 5(6):502-4. PubMed ID: 15536291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term memory loss associated with rosuvastatin.
    Galatti L; Polimeni G; Salvo F; Romani M; Sessa A; Spina E
    Pharmacotherapy; 2006 Aug; 26(8):1190-2. PubMed ID: 16863497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Golf-inhibiting gynecomastia associated with atorvastatin therapy.
    Hammons KB; Edwards RF; Rice WY
    Pharmacotherapy; 2006 Aug; 26(8):1165-8. PubMed ID: 16863492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rosuvastatin-induced gynaecomastia.
    Picolos MK; Zeniou V; Michalis A
    Clin Endocrinol (Oxf); 2010 Sep; 73(3):421-2. PubMed ID: 20346003
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of benefits and risks of rosuvastatin versus atorvastatin from a meta-analysis of head-to-head randomized controlled trials.
    Wlodarczyk J; Sullivan D; Smith M
    Am J Cardiol; 2008 Dec; 102(12):1654-62. PubMed ID: 19064019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of rosuvastatin.
    Shepherd J; Hunninghake DB; Stein EA; Kastelein JJ; Harris S; Pears J; Hutchinson HG
    Am J Cardiol; 2004 Oct; 94(7):882-8. PubMed ID: 15464670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The safety of rosuvastatin in comparison with other statins in over 25,000 statin users in the Saskatchewan Health Databases.
    García-Rodríguez LA; González-Pérez A; Stang MR; Wallander MA; Johansson S
    Pharmacoepidemiol Drug Saf; 2008 Oct; 17(10):953-61. PubMed ID: 18425987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of rosuvastatin: update on 16,876 rosuvastatin-treated patients in a multinational clinical trial program.
    Shepherd J; Vidt DG; Miller E; Harris S; Blasetto J
    Cardiology; 2007; 107(4):433-43. PubMed ID: 17363845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressant-selective gynecomastia.
    Kaufman KR; Podolsky D; Greenman D; Madraswala R
    Ann Pharmacother; 2013 Jan; 47(1):e6. PubMed ID: 23324513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and tolerability of every-other-day rosuvastatin dosing in patients with prior statin intolerance.
    Backes JM; Venero CV; Gibson CA; Ruisinger JF; Howard PA; Thompson PD; Moriarty PM
    Ann Pharmacother; 2008 Mar; 42(3):341-6. PubMed ID: 18285559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of rosuvastatin and atorvastatin when force-titrated in patients with primary hypercholesterolemia: results from the ECLIPSE study.
    Faergeman O; Hill L; Windler E; Wiklund O; Asmar R; Duffield E; Sosef F;
    Cardiology; 2008; 111(4):219-28. PubMed ID: 18434729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of restricted reimbursement on the use of statins in Finland: a register-based study.
    Martikainen JE; Saastamoinen LK; Korhonen MJ; Enlund H; Helin-Salmivaara A
    Med Care; 2010 Sep; 48(9):761-6. PubMed ID: 20706164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosuvastatin-acenocoumarol interaction.
    Mondillo S; Ballo P; Galderisi M
    Clin Ther; 2005 Jun; 27(6):782-4. PubMed ID: 16117985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The comparative safety of rosuvastatin: a retrospective matched cohort study in over 48,000 initiators of statin therapy.
    McAfee AT; Ming EE; Seeger JD; Quinn SG; Ng EW; Danielson JD; Cutone JA; Fox JC; Walker AM
    Pharmacoepidemiol Drug Saf; 2006 Jul; 15(7):444-53. PubMed ID: 16761308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Summaries for patients. Treatment trials to determine whether statins are the cause of a patient's discomfort.
    Ann Intern Med; 2014 Mar; 160(5):I-34. PubMed ID: 24737270
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of statin treatment on platelet inhibition by clopidogrel - a randomized comparison of rosuvastatin, atorvastatin and simvastatin co-treatment.
    Malmström RE; Ostergren J; Jørgensen L; Hjemdahl P;
    J Intern Med; 2009 Nov; 266(5):457-66. PubMed ID: 19549094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results from a rosuvastatin historical cohort study in more than 45,000 Dutch statin users, a PHARMO study.
    Goettsch WG; Heintjes EM; Kastelein JJ; Rabelink TJ; Johansson S; Herings RM
    Pharmacoepidemiol Drug Saf; 2006 Jul; 15(7):435-43. PubMed ID: 16761304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute renal failure with the combined use of rosuvastatin and fenofibrate.
    Buyukhatipoglu H; Sezen Y; Guntekin U; Kirhan I; Dag OF
    Ren Fail; 2010 Jun; 32(5):633-5. PubMed ID: 20486848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin, the black box.
    Hatem S; Boccara F
    Arch Cardiovasc Dis; 2008 Jun; 101(6):377-9. PubMed ID: 18809149
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.